Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ReNeuron Group PLC

+ Add to Watchlist

RENE:LN

5.500 GBp 0.375 7.32%

As of 11:35:02 ET on 05/22/2015.

Company Profile for ReNeuron Group PLC (RENE)

ReNeuron Group PLC is a United Kingdom-based adult stem cell research and development company. The Company is applying its novel stem cell platform technologies in the development of stem cell therapies to serve significant and unmet or poorly-met clinical needs. ReNeuron Group has also leveraged its stem cell technologies into the non-therapeutic areas such as drug discovery.

Contact Information

ReNeuron Group PLC

10 Nugent Road
Surrey Research Park
Surrey, GU2 7AF
United Kingdom
Phone: 44-1483-302-560
Fax: 44-1483-534-864

Key Executives for ReNeuron Group PLC (RENE)

Terje Olav HelleboeChief Executive OfficerMichael Elliott HuntChief Financial Officer
John SindenChief Scientific Ofcr/Co-FounderRichard MoulsonSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil